At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 1, 2026 at 16:15 ET
Viking Therapeutics is holding its 2026 annual shareholder meeting to vote on director elections, auditor selection, and executive compensation. This is a routine annual filing with no material financial or operational updates.
- Annual shareholder meeting scheduled for May 19, 2026
- Voting on election of two Class II directors: J. Matthew Singleton and S. Kathryn Rouan, Ph.D.
- Ratification of CBIZ CPAS P.C. as independent auditors
- Advisory vote on executive compensation
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access